Table of Content

1. Overview of Pharmaceutical Distribution Industry
1.1 Definition
1.2 Industry Chain
1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
1.3.1 Strength of Pharmaceutical Chain Enterprises
1.3.2 Weakness of Pharmaceutical Chain Enterprises


2. Pharmaceutical Distribution Industry in China
2.1 Development Environment
2.1.1 Policy
2.1.2 Economy
2.1.3 Medical Institution
2.1.4 Health Expenditure
2.1.5 Aging
2.1.6 Per Capita Disposable Income
2.2 Status Quo
2.3 Market Size
2.4 Market Structure
2.5 Competitive Landscape
2.6 Development Trends
2.6.1 Pharmaceutical E-commerce Becomes an Important Model
2.6.2 Capital Market Plays a Bigger Role in Integration of Enterprises
2.6.3 Favorable Policies Push up Market Concentration
2.6.4 Growing Trend towards Regionalization
2.6.5 Wholesale-retail Integration Spurs Industry Consolidation
2.6.6 Prescription Leaks Facilitate the Industry
2.6.7 Individual Pharmacies Withdraw, while Chain Pharmacies Prevail
2.6.8 The Thriving Pharmaceutical O2O


3 Chinese Drug Retail Market
3.1 Market Size
3.2 Gross Margin and Net Profit Margin
3.3 Quantity
3.3.1 Top100 Pharmacy Chains
3.3.2 Online Pharmacy
3.3.3 Independent Pharmacy
3.3.4 Proportion of Pharmacies Newly Opened and Closed
3.4 Coverage of Medical Insurance
3.5 Per Customer Transaction


4. Major Enterprises
4.1 China National Accord Medicines Corporation Ltd.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Pharmaceutical Distribution Business
4.1.6 Development Strategy
4.2 Nanjing Pharmaceutical Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Pharmaceutical Distribution Business
4.2.6 Development Strategy
4.3 Shanghai No.1 Pharmacy Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Development Strategy
4.4 China National Medicines Corporation Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5Pharmaceutical Distribution Business
4.4.6 Development Strategy
4.5 Huadong Medicine Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Pharmaceutical Distribution Business
4.5.6 Development Strategy
4.6 Cachet Pharmaceutical Co., Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Pharmaceutical Distribution Business
4.6.6 Development Strategy
4.7 Jointown Pharmaceutical Group Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Pharmaceutical Distribution Business
4.7.6 Development Strategy
4.8 Realcan Pharmaceutical Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Pharmaceutical Distribution Business
4.8.6 Development Strategy
4.9 Shanghai Pharmaceuticals Holding Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Pharmaceutical Distribution Business
4.9.6 Development Strategy
4.10 Zhejiang Int’l Group Co., Ltd.
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Gross Margin
4.10.5 Pharmaceutical Distribution Business
4.10.6 Development Strategy
4.11 Zhejiang Zhenyuan Share Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Pharmaceutical Distribution Business
4.11.6 Development Strategy
4.12 China Meheco Co., Ltd.
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Pharmaceutical Distribution Business
4.12.6 Development Strategy
4.13 Charmacy Pharmaceutical Co., Ltd.
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Gross Margin
4.13.5 Pharmaceutical Distribution Business
4.13.6 Development Strategy
4.14 Luyan Pharma Co., Ltd.
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 Gross Margin
4.14.5 Pharmaceutical Distribution Business
4.14.6 Development Strategy
4.15 China Resources Pharmaceutical Group Limited
4.15.1 Profile
4.15.2 Operation
4.15.3 Revenue Structure
4.15.4 Gross Margin
4.15.5 Pharmaceutical Distribution Business
4.15.6 Development Strategy
4.16 DaShenLin Pharmaceutical Group Co., Ltd.
4.16.1 Profile
4.16.2 Operation
4.16.3 Revenue Structure
4.16.4 Gross Margin
4.16.5 Pharmaceutical Distribution Business
4.16.6 Development Strategy



List of Figures


China Pharmaceutical Distribution Channel
Difference between Pure Marketing and Allocation in China’s Pharmaceutical Distribution
Policies on China’s Pharmaceutical Distribution Industry, 2016-2020
China’s GDP, 2012-2019
Number of Medical and Healthcare Institutions in China, 2015-2019
Number of Hospitals in China, 2009-2019
Number of Hospitals in China by Economic Type, 2009-2019
Health Expenditure in China, 2010-2019
Health Expenditure in China, 2018-2025E
Population Aged over 65 in China, 2009-2025E
Residents’ Per-capita Disposable Income and YoY Growth in China, 2011-2019
Promotion and Implementation of the Two-Invoice Policy
Pharmaceutical Distribution Market Size and YoY Growth in China, 2006-2019
Pharmaceutical Distribution Market Size and YoY Growth in China, 2019-2026E
Pharmaceutical Distribution Sales Structure in China by Type, 2018
Pharmaceutical Distribution Sales Structure in China by Region, 2018
Pharmaceutical Distribution Revenue in China by Region, 2018
Top 20 Pharmaceutical Distribution Companies in China by Operating Revenue, 2017-2018
Revenue of Major Pharmaceutical Distribution Companies in China, 2013-2019
Net Income of Major Pharmaceutical Distribution Companies in China, 2013-2019
Pharmaceutical Distribution Revenue of Major Pharmaceutical Distribution Companies in China, 2013-2019
Total Sales of Pharmaceutical E-commerce Direct Reporting Enterprises (Which Are Recommended by the Local Competent Authority and Confirmed by the Ministry of Commerce and Then are Included in the Direct Designated Statistics) (without Certificate A) in China, 2015-2018
Capital Layout of China’s Pharmaceutical Retail Industry in Recent Years
China’s Tier-1 and Tier-2 Capital Investment in Pharmacies by Region
Regulatory Policies Prompt the Concentration of Retail Pharmacy Market in China, 2015-2019
Representative Pharmaceutical Distribution Enterprises in China by Regional Market
Policies for Prescription Outflow in China, 2015-2018
Top 10 Pharmacies in China by Prescription Drug Sales, 2018
BATJ’s Layout in Pharmaceutical O2O Platforms in China
Drug Retail Market Size and YoY Growth in China, 2012-2019
Drug Retail Market Size and YoY Growth in China, 2019-2026E
Average Gross Margin of Sample Pharmacies in China by Value, 2010-2019
Average Net Margin of Sample Pharmacies in China by Value, 2010-2019
Number of Drug Retail Chains in China, 2012-2018
Drug Retail Chains in China by Number of Stores, 2012-2018
Number of Independent Retail Drugstores in China, 2012-2018
Pharmaceutical Retail Chain Ratio in China, 2009-2018
Top 100 Pharmacy Chains in China by Total Revenue, 2018
Top 100 Pharmacy Chains via Direct Sales Mode in China, 2019
Top 50 Online Pharmacies in China, 2019
Top 30 Independent Pharmacies in China by Revenue, 2018
Proportion of New Pharmacies in China, 2014-2018
Enterprises Whose New Pharmacies Made up over 30% in China, 2018
Average Investment in a Pharmacy in China, 2014-2018
Proportion of Closed Pharmacies in China, 2014-2018
Enterprises Whose Closed Pharmacies Made up over 5% in China, 2018
Proportion of Pharmacies Covered by Medical Insurance in China, 2014-2018
Enterprises Owning 600 Pharmacies Covered by Medical Insurance in China, 2018
Enterprises Whose 95% Pharmacies Were Covered by Medical Insurance in China, 2018
Per Customer Transaction of Pharmacies in China, 2013-2018
Enterprises Whose Pharmacies Secured the Per Customer Transaction over RMB135 in China, 2018
Revenue and Net Income of China National Accord Medicines, 2013-2019
Revenue Breakdown of China National Accord Medicines by Business, 2015-2019
Gross Margin of China National Accord Medicines’ Main Business, 2016-2019
Number of Stores of China National Accord Medicines, as of the end of June 2019
O2O Platform Sales of China National Accord Medicines, 2019H1
Revenue and Net Income of Nanjing Pharmaceutical, 2013-2019
Revenue Breakdown of Nanjing Pharmaceutical by Business, 2015-2019
Revenue Breakdown of Nanjing Pharmaceutical by Region, 2015-2019
Gross Margin of Nanjing Pharmaceutical by Business, 2015-2019
Revenue and Net Income of Shanghai No.1 Pharmacy, 2013-2019
Revenue Breakdown of Shanghai No.1 Pharmacy by Business, 2014-2019
Revenue Structure of Shanghai No.1 Pharmacy by Business, 2014-2019
Gross Margin of Shanghai No.1 Pharmacy, 2016-2019
Gross Margin of Shanghai No.1 Pharmacy by Business, 2014-2018
Revenue and Net Income of China National Medicines, 2013-2019
Revenue Breakdown of China National Medicines by Business, 2014-2019
Revenue Structure of China National Medicines by Business, 2014-2019
Revenue Breakdown of China National Medicines by Region, 2014-2019
Revenue Structure of China National Medicines by Region, 2014-2019
Gross Margin of China National Medicines, 2014-2019
Gross Margin of China National Medicines by Business, 2014-2019
Revenue and Net Income of Huadong Medicine, 2013-2019
Revenue Breakdown of Huadong Medicine by Sector, 2014-2019
Revenue Structure of Huadong Medicine by Sector, 2014-2019
Gross Margin of Huadong Medicine by Sector, 2014-2019
Revenue and Net Income of Cachet Pharmaceutical, 2013-2019
Revenue Breakdown of Cachet Pharmaceutical by Business, 2014-2019
Revenue Structure of Cachet Pharmaceutical by Business, 2014-2019
Revenue Breakdown of Cachet Pharmaceutical by Region, 2014-2019
Revenue Structure of Cachet Pharmaceutical by Region, 2014-2019
Gross Margin of Cachet Pharmaceutical’s Pharmaceutical Wholesale Business, 2014-2019
Revenue and Net Income of Jointown Pharmaceutical Group, 2013-2019
Revenue Breakdown of Jointown Pharmaceutical Group by Business, 2014-2019
Revenue Structure of Jointown Pharmaceutical Group by Business, 2014-2019
Gross Margin of Jointown Pharmaceutical Group by Business, 2014-2019
Main Pharmaceutical Products Wholesaled by Jointown Pharmaceutical Group
Revenue and Net Income of Realcan Pharmaceutical, 2013-2019
Revenue Breakdown of Realcan Pharmaceutical by Business, 2014-2019
Revenue Structure of Realcan Pharmaceutical by Business, 2014-2019
Gross Margin of Realcan Pharmaceutical by Business, 2014-2019
Revenue and Net Income of Shanghai Pharmaceuticals Holding, 2013-2019
Revenue Breakdown of Shanghai Pharmaceuticals Holding by Business, 2014-2019
Revenue Structure of Shanghai Pharmaceuticals Holding by Business, 2014-2019
Revenue Breakdown of Shanghai Pharmaceuticals Holding by Region, 2014-2019
Gross Margin of Shanghai Pharmaceuticals Holding by Business, 2014-2019
Revenue and Net Income of Zhejiang Int’l Group, 2013-2019
Revenue Breakdown of Zhejiang Int’l Group by Business, 2017-2019
Gross Margin of Zhejiang Int’l Group’s Pharmaceutical Sales Business, 2016-2019
Revenue and Net Income of Zhejiang Zhenyuan, 2013-2019
Revenue Breakdown of Zhejiang Zhenyuan by Business, 2014-2019
Revenue Structure of Zhejiang Zhenyuan by Business, 2014-2019
Gross Margin of Zhejiang Zhenyuan by Business, 2014-2019
Revenue and Net Income of China Meheco, 2013-2019
Revenue Breakdown of China Meheco by Business, 2014-2019
Revenue Structure of China Meheco by Business, 2014-2019
Gross Margin of China Meheco by Business, 2014-2019
Revenue and Net Income of Charmacy Pharmaceutical, 2013-2019
Revenue Breakdown of Charmacy Pharmaceutical by Product/Client, 2013-2019
Revenue Structure of Charmacy Pharmaceutical by Product/Client, 2013-2019
Gross Margin of Charmacy Pharmaceutical, 2013-2019
Luyan Pharma’s Investment Projects with Raised Funds by Initial Public Offerings
Revenue and Net Income of Luyan Pharma, 2013-2019
Revenue Breakdown of Luyan Pharma by Business, 2014-2019
Revenue Structure of Luyan Pharma by Business, 2014-2019
Gross Margin of Luyan Pharma’s Pharmaceutical Wholesale Business, 2014-2019
Revenue and Net Income of China Resources Pharmaceutical Group, 2013-2019
Revenue Breakdown of China Resources Pharmaceutical Group by Business, 2013-2019
Revenue Structure of China Resources Pharmaceutical Group by Business, 2013-2019
Gross Margin of China Resources Pharmaceutical Group, 2013-2019
Development Strategy of China Resources Pharmaceutical Commercial Group Co., Ltd., 2020
Revenue and Net Income of DaShenLin Pharmaceutical, 2014-2019
Revenue Breakdown of DaShenLin Pharmaceutical by Business, 2014-2018
Revenue Structure of DaShenLin Pharmaceutical by Business, 2014-2018
Gross Margin of DaShenLin Pharmaceutical, 2013-2018